Studies of the cellular immunology and protein structure of human and mouse CD1 proteins reveal these to be a family of antigen-presenting molecules that allow T cells to recognize lipid and glycolipid antigens of microbial pathogens. In an immune response, the recognition of protein antigens by T cells requires a process known as antigen presentation, in which foreign proteins are broken down into peptide fragments within antigen-presenting cells and then displayed on the surface of these cells, where they can be recognized by T-cell antigen receptors. This process of presentation requires the class I and class II proteins encoded by genes of the major histocompatibility complex (MHC) that are specialized for binding and displaying peptide antigens. It has recently become clear, however, that T cells can also specifically recognize lipid and glycolipid antigens derived from pathogenic bacteria. How these non-protein antigens are recognized is becoming clear from studies of a family of proteins, known as CD1 proteins, which are now recognized to be antigenpresenting molecules, distinct from the MHC proteins, that provide a unique solution to the problem of displaying particular types of foreign antigen to T cells.
In an immune response, the recognition of protein antigens by T cells requires a process known as antigen presentation, in which foreign proteins are broken down into peptide fragments within antigen-presenting cells and then displayed on the surface of these cells, where they can be recognized by T-cell antigen receptors. This process of presentation requires the class I and class II proteins encoded by genes of the major histocompatibility complex (MHC) that are specialized for binding and displaying peptide antigens. It has recently become clear, however, that T cells can also specifically recognize lipid and glycolipid antigens derived from pathogenic bacteria. How these non-protein antigens are recognized is becoming clear from studies of a family of proteins, known as CD1 proteins, which are now recognized to be antigenpresenting molecules, distinct from the MHC proteins, that provide a unique solution to the problem of displaying particular types of foreign antigen to T cells.
CD1 proteins appear to be present in most or all mammals, but so far they have been extensively studied only in humans and mice [1, 2] . The human CD1 system consists of five closely linked, non-polymorphic genes that map to chromosome 1, and are thus unlinked to the MHC on chromosome 6. Four of the five CD1 genes are known to encode protein products -related, but distinct, CD1 isoforms known as CD1a, CD1b, CD1c and CD1d. Sequence comparisons show that these proteins can be classified into two separate groups: CD1a, CD1b and CD1c form group 1, and the significantly more divergent CD1d defines group 2. The mouse CD1 system is less complex, with only two, very closely related CD1 genes encoding the mCD1.1 and mCD1.2 proteins, both of which appear to be homologues of human CD1d.
CD1 proteins show striking structural similarities to MHC class I proteins. Thus, like MHC class I proteins, CD1 proteins consist of a transmembrane glycoprotein -the heavy chain -associated non-covalently with ␤ 2 microglobulin (␤ 2 m; Figure 1) . Furthermore, the extracellular portions of CD1 heavy chains are composed of three domains, designated ␣1, ␣2 and ␣3, which are similar in size to the three analogous domains of MHC class I heavy chains. At the amino-acid level, limited but significant homology -up to about 30% identity in ␣2 and ␣3, but undetectable in the ␣1 domain -is seen between the extracellular domains of CD1 proteins and the corresponding domains of MHC class I and II proteins. Thus the CD1 proteins clearly arose from the same ancestral lineage The subunit structures and domain organization of MHC class I (MHCI), MHC class II (MHCII) and CD1 antigen-presenting molecules, and their pathways of intracellular transport. The CD1b protein localizes prominently to endosomes, including the same intracellular compartments that are rich in MHCII molecules (MHCII compartments, MIICs). Preliminary evidence indicates that several, although probably not all, of the different CD1 isoforms show a similar pattern of intracellular localization. As indicated by the arrows, the pathway taken by CD1 proteins to the endosomes may involve recycling from the plasma membrane, as opposed to that taken by MHCII proteins, which are mainly targeted directly to the endosomal system from the transGolgi network. MHCI molecules are not found in endosomes, as they traffic directly to the cell surface via the default secretory pathway. Direct evidence that CD1 proteins are also functionally similar to MHC proteins, in that they can present antigens, has come mainly from studies of human group 1 CD1 proteins. In man, CD1a, CD1b and CD1c are prominently expressed on specialized antigen-presenting cells -most notably dendritic cells found in a wide variety of tissues -and are required for the presentation of antigens from mycobacteria to certain T cells ( [3, 4] and our unpublished data). A most remarkable and surprising finding came with the identification of the specific antigens recognized by these T cells: these antigens turned out not to be chemically related to the usual peptide antigens recognized by conventional MHC-restricted T cells, but instead proved to be various lipid and glycolipid components of the bacterial cell wall [5, 6] .
The first CD1-presented antigens to be purified to homogeneity were identified as mycolic acids, members of a family of branched long-chain fatty acids found abundantly in mycobacterial cell walls, with a general structure distinct from that of lipids from higher eukaryotes. Analyses of other mycobacterial antigens recognized by CD1-restricted T cells have confirmed this general theme, identifying the inositol-containing phospholipids lipoarabinomannan and phosphatidylinositol mannosides as antigens presented by CD1b (Figure 2 ). Although hydrophobic peptides isolated from a random peptide phage-display library have been found to bind with high affinity to the mouse CD1d homologue and sensitize CD1-expressing target cells for lysis by specific cytotoxic T lymphocytes [7] , all of the naturally occurring CD1-presented antigens described so far appear to be lipids or glycolipids.
While the full range of natural antigens that can be presented by CD1 proteins is not yet known, a common structural motif for CD1-presented antigens is suggested by the currently available data. All of the lipid and glycolipid antigens identified so far have a branched or dual acyl chain portion which imparts marked hydrophobicity to one end of the molecule; the other end contains various hydrophilic groups, such as carbohydrate residues, polar hydroxyls or a charged carboxylate. The effects of chemically modifying the antigens have confirmed that both the hydrophilic and hydrophobic ends of these structures are involved in their presentation to T cells and recognition as antigens [5, 6] .
As it is unlikely that the acyl chains of these antigens can remain exposed to solvent in an aqueous environment, these findings suggest a model for lipid-antigen binding by CD1, in which the hydrophobic moiety of the antigen forms a stable association with a putative hydrophobic binding-site in the CD1 protein. Indeed, the amino-acid sequences of the ␣1 and ␣2 domains of all CD1 proteins are unusually hydrophobic when compared to other antigen-presenting molecules, indicating that there is the potential for formation of a lipid-binding cavity in the three-dimensional structure of the folded protein [2] .
This expectation has now essentially been validated with the recent solution of the three-dimensional structure of a mouse CD1 protein (mCD1.1) by X-ray crystallography [8] . Although the structure is strikingly similar to an MHC class I molecule in many aspects of its overall extracellular form, it is substantially different in the region corresponding to the peptide-binding groove of an MHC molecule. Although narrow at its opening, the CD1 groove descends into a deep cavity lined almost entirely by nonpolar or hydrophobic amino-acid sidechains. The multiple distinct pockets for anchoring peptide sidechains seen in the peptide-binding grooves of all MHC molecules seem to merge into just two large pockets in the CD1 structure. At least one end of the CD1 hydrophobic cavity appears to be Dispatch R509 closed and, despite its large surface area, it has little capacity for the hydrogen-bonding interactions that are prominent between peptides and MHC class I and II proteins.
These features argue against CD1 having a typical peptide-binding function, and instead appear to indicate the presence of a site that is ideally suited to the binding of markedly hydrophobic ligands, such as the lipid and glycolipid bacterial antigens that have been shown to be presented to human CD1-restricted T cells. The crystal structure of this CD1 protein leads us to propose that the lipid tails of antigens such as mycolic acids and lipoarabinomannan anchor in the hydrophobic cavity of CD1, leaving the hydrophilic glycan-containing and oxygen-containing groups protruding from the CD1 molecule and accessible for interactions with T-cell receptors (Figure 3) . Interestingly, the mouse CD1 structure is described as containing a poorly defined unbranched density within the pockets of the deep hydrophobic groove [8] . Although this apparent bound material has not been precisely identified, its branched structure strongly suggests that it is not a peptide, and might in fact represent a bound acyl chain. An important future advance will be the solution of structures of CD1 proteins crystallized in the presence of bound lipid antigens of known structure, so as to visualize the protein-lipid interaction directly.
Another aspect of this model for CD1 function that remains to be resolved is the problem of antigen loading, that is, the mechanism by which lipid antigens are inserted into the hydrophobic cavity of the CD1 protein. Preliminary clues to how this may be accomplished come from studies of the intracellular transport and subcellular localization of CD1b. This protein contains a targeting motif within its short cytoplasmic tail that directs it to acidic endosomal compartments, including those compartments in which MHC class II molecules are loaded with peptide antigens before being transported to the membrane [9, 10] . Preliminary studies suggest that an acidic environment may induce conformational changes in CD1b, leading to greater accessibility of the hydrophobic binding-site to antigen (R.L. Modlin, personal communication). Furthermore, these compartments are known to harbor an extensive array of degradative enzymes, raising the possibility that enzymatic processing of lipids and glycolipids may occur either before or after their binding to CD1. In fact, for the large glycolipid antigen lipoarabinomannan, it appears likely that the carbohydrate moiety is extensively cleaved within acidic endosomes before it is presented on the cell surface by CD1b [6] . Whether similar mechanisms will apply for other forms of human CD1 or for the murine CD1 molecules remains to be determined.
What is the role of CD1-restricted, lipid-antigen-specific T cells in the overall immune response? In humans, studies have so far emphasized the potential role of these T cells in mycobacterial infections. Group 1 CD1 proteins are highly expressed on dendritic cells that infiltrate cutaneous granulomas in patients with Mycobacterium leprae infections who show effective immunity to this pathogen (S.A.P., P. Sieling and R.L. Modlin, unpublished observations). Furthermore, in vitro CD1-restricted T cells have been shown to secrete proinflammatory cytokines [6] , and also to kill mycobacterially-infected mononuclear phagocytes (S. Stenger and R.L. Modlin, personal communication).
More definitive studies on the role of the CD1 system in protective immunity are likely to involve animal models. In this regard, it is noteworthy that CD1-deficient mice generated by targeted gene disruption of both murine CD1 genes have recently been reported [11] . Studies in these animals so far have been limited to the analysis of a specialized subset of T cells that express a cell surface C-type lectin molecule called NK1. These NK1 + T cells are activated by recognition of mouse CD1 molecules, and respond by rapid secretion of large quantities of cytokines, particularly interleukin-4 [12] . These cells are lacking from CD1 mutant mice, and this correlates with a defect in splenic production of interleukin-4 upon T-cell stimulation under certain conditions in vivo. Perhaps more importantly, these mice now offer an opportunity to explore the extent of the contribution of the mouse CD1 system to immunity, including its possible role in the presentation of lipid antigens from various pathogens, such as mycobacteria and other persistent intracellular pathogens for which T-cell-mediated immunity is critical.
Thus, it is now clear that the CD1 system defines a new paradigm for T-cell recognition of foreign antigens. This unique adaptation of antigen-presenting cells represents another remarkably sophisticated and highly evolved approach to solving the problem of detecting microbial invasion, and increases the range of potential T-cell antigens by extending it to selected classes of microbial cellwall lipids and glycolipids that cannot be presented by the MHC system. By solving the problem of how to make oil and water mix, the CD1 system appears to have created an interface between the hydrophilic environment in which specific immune receptor proteins such as the T-cell receptor are able to function efficiently, and the hydrophobic environment in which antigenic lipids normally reside.
